This inventor holds 1 USPTO granted patent. Top assignee: Scinopharm Taiwan, Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Kau-Ming Chen: Innovator in Pharmaceutical Synthesis
Introduction
Kau-Ming Chen is a notable inventor based in Tainan County, Taiwan. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of key intermediates for cancer treatment drugs.
Latest Patents
Kau-Ming Chen holds a patent for the "Process for the preparation of 7-alkyl-10-hydroxy-20(S)-camptothecin." This patent outlines an efficient synthesis process for 7-ethyl-10-hydroxy-20(S)-camptothecin, a crucial intermediate in the production of Irinotecan, a chemotherapy medication. The process utilizes readily available 20(S)-camptothecin, allowing for the creation of various other tecan compounds through corresponding intermediates.
Career Highlights
Kau-Ming Chen is associated with Scinopharm Taiwan, Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficiency of drug synthesis, which is vital for the pharmaceutical industry.
Collaborations
Kau-Ming Chen has collaborated with notable colleagues, including Chien-Hsing Lin and Yung-Fa Chen. Their combined expertise contributes to the innovative research environment at Scinopharm Taiwan, Ltd.
Conclusion
Kau-Ming Chen's contributions to pharmaceutical synthesis exemplify the impact of innovation in drug development. His work not only advances scientific knowledge but also plays a crucial role in improving cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile